• Staurosporine: Broad-Spectrum Serine/Threonine Kinase Inhibi

  2026-04-22

  Staurosporine is a potent, broad-spectrum serine/threonine protein kinase inhibitor used extensively in cancer research and apoptosis assays. Its high affinity for PKC isoforms and VEGF receptor kinases underlies its role as a benchmark apoptosis inducer and anti-angiogenic agent. Sourced from APExBIO, Staurosporine enables reproducible, high-sensitivity kinase pathway interrogation.

• Lactate–GPR81–FARP1 Axis Enables Insulin-Independent Glucose

  2026-04-21

  This study uncovers a lactate-triggered signaling pathway (GPR81–FARP1–RAC1) that promotes glucose uptake independently of insulin, with significant implications for hyperglycemia management. By detailing the molecular mechanisms and physiological relevance, the research offers new avenues for metabolic disease intervention beyond classical insulin signaling.

• FAPα-Sensitive Nanoparticle Probes for Noninvasive Tumor Dia

  2026-04-21

  This study introduces a synthetic urinary probe–coated magnetic nanoparticle system that selectively responds to fibroblast activation protein α (FAPα) activity within solid tumors, enabling noninvasive cancer diagnosis via urinary peptide detection. The approach demonstrates high specificity and diagnostic accuracy for FAPα-positive tumor identification, providing a promising platform for early cancer detection and potential clinical translation.

• Ciprofloxacin Workflows: Advancing Antimicrobial Resistance

  2026-04-20

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, enables high-fidelity modeling of antimicrobial resistance and DNA replication inhibition at the bench. This guide delivers workflow enhancements, troubleshooting insights, and data-driven protocol parameters leveraging APExBIO’s high-purity Ciprofloxacin for cutting-edge resistance research.

• 3-(1-methylpyrrolidin-2-yl)pyridine (N2703): Precision Tools

  2026-04-20

  Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) empowers advanced research into cellular signaling pathway modulation. This article offers a unique, in-depth analysis of N2703's mechanistic applications and practical assay guidance, setting it apart from standard overviews.

• Sildenafil Citrate: Applied Workflows for PDE5 Inhibition Re

  2026-04-19

  Sildenafil Citrate from APExBIO empowers advanced studies in cGMP signaling, vascular relaxation, and proteoform-specific drug targeting. This guide translates recent proteomics breakthroughs into actionable protocols, troubleshooting advice, and comparative insights for researchers investigating vascular function and signal transduction.

• Captopril as an ACE Inhibitor: Protocols and Advanced Resear

  2026-04-18

  Captopril stands out as a gold-standard ACE inhibitor, supporting not only hypertension research but also pioneering studies in oncology and bradykinin pathway modulation. This guide details practical workflows, troubleshooting insights, and novel applications, enabling scientists to maximize the compound's potential across cardiovascular and cancer research.

• Deciphering Aneugenic Mechanisms: Molecular Profiling with 2

  2026-04-17

  This study introduces a two-tiered molecular mechanism assay to distinguish between tubulin interactors and mitotic kinase inhibitors among 27 reference aneugens. By integrating multiplex biomarker flow cytometry and machine learning, the research establishes a robust framework for elucidating aneugenic mechanisms relevant to cancer biology and preclinical safety assessment.

• GLT-1 Upregulation Counters CB1-CREB Pathway Dysfunction in

  2026-04-16

  This study demonstrates that enhancing GLT-1 expression in astrocytes mitigates neuronal apoptosis and cognitive deficits after traumatic brain injury (TBI) by suppressing the CB1-CREB signaling pathway. These findings clarify the mechanistic link between endocannabinoid signaling, glutamate transport, and neuroprotection, offering new strategies for memory impairment research.

• Epalrestat: Aldose Reductase Inhibitor for Neuroprotection R

  2026-04-15

  Epalrestat, a high-purity aldose reductase inhibitor from APExBIO, excels in both diabetic complication and neurodegeneration models by targeting polyol pathway and KEAP1/Nrf2 signaling. This article details optimized workflows, real-world troubleshooting, and actionable tips to maximize reproducibility in oxidative stress and Parkinson’s disease research.

• OTUD3 Stabilization of SLC7A11 Drives Ferroptosis Resistance

  2026-04-14

  The referenced study elucidates a new mechanism of sunitinib resistance in clear cell renal cell carcinoma (ccRCC), showing that OTUD3 overexpression stabilizes SLC7A11 and suppresses ferroptosis. These findings highlight the SLC7A11–GSH–GPX4 axis as a critical therapeutic target and provide a foundation for improving treatment strategies against drug-resistant ccRCC.

• CDK4/6 and BET Inhibition Synergizes via Wnt/β-catenin Block

  2026-04-13

  Gu et al. (2025) reveal that combining CDK4/6 and BET inhibitors synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth by modulating the GSK3β-mediated Wnt/β-catenin pathway. This work clarifies mechanisms underlying EMT and resistance in PDAC, providing a rationale for dual-target strategies and informing the use of Wnt pathway inhibitors in translational research.

• Triacetin (Glyceryl Triacetate): Advanced Workflows in Bioch

  2026-04-13

  Triacetin (glyceryl triacetate) delivers unmatched flexibility as a lipid-related biochemical reagent, enabling apoptosis induction in glioblastoma cells, metabolic modulation, and safe application in ocular models. This article details robust, evidence-based workflows and troubleshooting strategies, positioning Triacetin from APExBIO as a cornerstone for reliable, reproducible results.

• Z-YVAD-FMK: Benchmark Caspase-1 Inhibitor for Inflammation S

  2026-04-12

  Z-YVAD-FMK is a potent, selective, and irreversible caspase-1 inhibitor used in apoptosis and pyroptosis research. Its robust selectivity and cell-permeable design make it a standard tool for dissecting inflammasome pathways and cytokine release mechanisms. APExBIO's formulation supports reproducible results in both cell-based and animal models.

• Mianserin HCl in Precision Antidepressant and Antipathogenic

  2026-04-12

  Explore the multidimensional research utility of Mianserin HCl, a 5-HT2 receptor antagonist, with advanced insights into its mechanistic selectivity, inclusion complexation, and assay design. This article delivers unique, evidence-backed guidance for translational neuroscience and antipathogenic studies.

15446 records 1/1030 page Next 12345 下5页 Last page